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Abstract
Background: The role of extremely skewed X-chromosome inactivation (XCI) has been questioned in the pathogenesis
of recurrent spontaneous abortion (RSA) but the results obtained were conflicting.
Aims: We therefore investigated the XCI patterns in peripheral blood DNA obtained from 80 patients who had RSA
and 160 age-matched controls.
Methods: Pregnancy history, age, karyotype, and disease information was collected from all subjects. The methylation
status of a highly polymorphic cytosine-adenine-guanine repeat in the androgen-receptor (AR) gene was determined
by use of methylation-sensitive restriction enzyme HpaII and polymerase chain reaction.
Results: Skewed XCI (> 85% skewing) was observed in 13 of the 62 patients informative for the AR polymorphism
(20.9%), and eight of the 124 informative controls (6.4%) (P = 0.0069; χ2 test). More importantly, extremely skewed
XCI, defined as > 90% inactivation of one allele, was present in 11 (17.7%) patients, and in only two controls
(P = 0.0002; χ2 test).
Conclusions: These results support the interpretation that disturbances in XCI mosaicism may be involved in the
pathogenesis of RSA.
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Introduction
Recurrent spontaneous abortion (RSA) is an important
medical problem that affects 1–2% of couples wishing to have
children. It is defined as loss of three or more consecutive
pregnancies prior to 20 week of gestation.1 The aetiologic
factors that have been implicated in RSA include anatomical
abnormalities (15%), infectious agents (1–2%), hormonal
imbalances (20%), immunologic factors (20%) and genetic
disorders (2–5%).2,3 However, a large proportion of couples
(37–79%) receive no explanation for their pregnancy losses.
Based on the observation that an Xq28 deletion is associated
with a high spontaneous abortion rate and familial skewed
X-chromosome inactivation (XCI) in a large family,4 male
lethal X-linked mutations that cause skewed XCI in female
carriers was proposed as an aetiologic factor in RSA.
X-chromosome inactivation is a physiologic event that takes
place during early embryonic development and results in the
transcriptional silencing of one of the two X-chromosomes
in females.5 The inactive X can be either paternally or
maternally derived in different cells of the same individual,
and once the decision as to which X to inactivate is made in a
particular cell, all the clonal descendants of that cell abide by
the decision. Therefore, females who are heterozygous for
X-linked genes are mosaics of two cell types, with either the
paternal or the maternal alleles active. The choice of which
X to inactivate is generally a random event.6 However, under
extraordinary circumstances, exclusive or almost exclusive
inactivation of one X-chromosome which leads to skewed
XCI may be observed.7,8 According to the ‘male lethal
X-linked mutations as a cause of recurrent abortions’ model,4
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X-chromosomal mutations that are cell lethal or associated
with cell-growth disadvantage could be tolerated in females
as a result of the XCI process. This means that in those cells
in which the mutant X-chromosome is the active X, cell death
eventually occurs during development, and the XCI pattern
becomes skewed. However, at the phenotypic level, the carrier
female lives and exhibits some (if not no) symptoms. However,
in males, as there is only one X-chromosome that is always
active, the putative cell lethal mutation becomes a male lethal
trait, and thus contributes to the aetiology of RSA.
In the studies conducted to test the hypothesis that skewed
XCI may be involved in the pathogenesis of RSA, both
supporting9–13 and refuting14,15 results have been obtained
(Table 1). We therefore investigated the peripheral blood XCI
patterns of controls and females who experience recurrent




Eighty Caucasian women diagnosed with RSA, and 160
apparently healthy female controls, were genotyped to deter-
mine whether women with a history of RSA have a greater
frequency of extremely skewed XCI than control subjects.
The ethics review board of the participating institutions
approved the study protocol. Pregnancy history, age, and
disease information, accompanied by informed consent, was
obtained from all subjects. We included those cases with
three or more clinically recognised spontaneous abortions of
unknown cause. A positive urine pregnancy test or serum βhCG
and evidence of the loss of conception products accompanied
by vaginal bleeding, or ultrasonographic findings of fetal
demise with subsequent reduction in serum βhCG, were used
to confirm spontaneous abortion. While ectopic or molar
pregnancies were excluded, only those abortions that have
occurred before week 20 of gestation were included in the study.
Clinical evaluation of the cases excluded anatomic, cytogenetic,
infectious, immunologic, hormonal, and social/exposure
as causes of spontaneous abortion.2,3 Also abnormal hystero-
salpingogram, antiphospholipid antibodies, or connective tissue
disorder were included in the exclusion criteria. While all of
the RSA cases were karyotyped using peripheral blood
samples, this was not done in the control group because of the
lack of an indication for cytogenetic studies. Gravida 2, para
2 women with no history of pregnancy loss comprised the
control group. The mean age of the cases and controls were
30.4 ± 5 (mean ± SD; range = 22–42 years), and 32.4 ± 4.9
years (range = 21–47 years), respectively.
X-chromosome inactivation study
DNA was extracted from 10 mL venous blood samples of
patients and controls using Nucleospin DNA isolation kit
(Macherey-Nagel, Dueren, Germany). Genotyping of a
polymorphic site in the androgen receptor gene (AR) was
performed and quantified to assess the XCI patterns as
described.16 The degree of skewing was estimated by an assay
based on a methylation-sensitive HpaII restriction site located
near the AR gene. This site is methylated on the inactive X,
and unmethylated on the active X-chromosomes. When the
genomic DNA is cleaved with HpaII prior to polymerase chain
reaction (PCR), only the methylated AR allele, which represents
the inactive X-chromosome, is amplified. A trinucleotide
cytosine-adenine-guanine (CAG) repeat polymorphism located
within the amplified region is used to distinguish between the
two alleles. For each patient and control two separate PCRs,
with or without HpaII treatment, were performed using the
same set of primers. Male DNA with cytogenetically verified
46XY karyotype was used as control for complete digestion.
All of the PCR products, before and after digestion, were
separated by employing two independent detection methods.
One is electrophoretic separation of the alleles in 4% MetaPhor
agarose (FMC Bioproducts, Rockland, ME, USA) and
ethidium bromide staining. The other is separation of radio-
active PCR products (α-[33P]-dCTP) (PerkinElmer, Wellesley,
MA, USA) on 8% sequencing gels. Densitometric analysis of
the alleles was performed using the Multi-Analyst software
version 1.1 (Bio-Rad Laboratories Inc., Hercules, CA, USA).
The results of the densitometric analyses included normali-
sation of the ratios based on the non-digested samples by
dividing the allele ratio of the digested sample by the ratio of
the non-digested sample from the same specimen. The use
of this ratio corrects for preferential amplification of one
allele, which often occurs for the shorter microsatellite allele.
The results from control and test groups were compared by
the χ2 test with Yates’ correction.
Results
X-chromosome inactivation status was found to be informative
in 77.5% of both the cases (62/80) and the controls (124/160).
Only those individuals whose alleles resolve adequately for
densitometric analysis were included in the study. Extremely
skewed XCI was present in 11 (17.7%) cases and in two (1.6%)
controls (P = 0.0002) (Table 2). Extremely skewed XCI,
defined as > 90% inactivation of one allele, is observed in ∼1–7%
of females aged 25 or younger, and in ∼2–16% of women aged
60 years or older.17,18 When XCI values between 85 and 89%
Table 1 Studies of skewed X-chromosome inactivation and
recurrent spontaneous abortion (RSA)
Study
No. (%) observed 
with > 90% skewing
RSA Control
Lanasa et al. 199910 7/48 (14.6) 1/67 (1.5)
Sangha et al. 199911 14/76 (18) 6/111 (5)
Uehara et al. 200112 7/42 (16.7) 2/36 (5.6)
Beever et al. 200313 25/207 (12) 7/102 (7)
Sullivan et al. 200314 7/106 (6.6) 4/102 (3.9)
Kim et al. 200415 1/45 (2.2) 5/54 (9.3)
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were also considered, skewed XCI was observed in 13 of the 62
(20.9%) informative cases, and eight of the 124 (6.4%) controls
(P = 0.0069). These results indicate that extremely skewed
XCI is more frequent in RSA cases than in controls, and raises
the important question as to what causes this observation.
Discussion
Skewed XCI could originate from primary (bias in the initial
choice) or secondary (selection following random XCI)
causes.8 Two different hypotheses have been proposed to
explain the aetiology of skewed XCI in women who experience
RSA: (i) male lethal X-linked mutations4,19 and (ii) a
reduction of the size of the follicular pool13 associated with
skewed XCI and trisomic pregnancies. A gender bias towards
female offspring among liveborn children and maternal
inheritance of skewed X-inactivation was documented in
conjunction with the first hypothesis. However, a significant
excess of boys among live births was observed in females with
skewed XCI who were ascertained on the basis of trisomic
pregnancies. Among our 11 patients with extreme skewing
(> 90%), only three patients had live births and the observed
female : male ratio is 3 : 1 (Table 3). Deviation from the
expected female : male ratio of 1 : 1 raises the possibility that
male lethal X-linked mutations could be an aetiologic factor
in our RSA cases, at least in the group of patients with extreme
skewing. In addition to deleterious X-linked mutations,
X-autosome translocations, normal ageing, twining, confined
placental mosaicism, reduction of the size of the follicular
pool, monoclonal expansion of peripheral blood cells, and
environmental insults, such as chemotherapy, are examples
of secondary causes. Some of these factors are unlikely to be
involved in our patients: for example only those patients with
a normal karyotype were included in the study, excluding
the potential contribution of X-autosome translocations.
Twining, because of negative history, and ageing, because of
the mean age of diagnosis at 30.4 ± 5 years, are also highly
unlikely. A history or present diagnosis of haematologic
malignancies, which may be associated with monoclonal
expansion of peripheral blood cells, or exposure to environ-
mental insults, such as chemotherapy, was not documented
in any study subject. With respect to the primary causes of
skewed XCI, we do not think dysfunction of gene(s) that
regulates XCI20 could be implicated in the aetiology of RSA
as dosage compensation for X-linked genes is not physiolog-
ically required in XY cells and therefore is not expected to
be lethal in male fetuses. Our findings also leave us with the
question of why some studies did not show a statistically
significant association between RSAs and skewed XCI
patterns.14,15 It is important to note that a heterogeneous group
of aetiologic factors is known to contribute to the development
of RSAs,2,3 and that small sample size15 may influence the
outcome of statistical analyses.
We plan to direct our future efforts towards the ascertain-
ment of extended pedigrees to assess the parental origin of the
inactive X-chromosome. In addition, detailed high-resolution
genomic analysis by newer molecular techniques, such as
comparative genomic hybridisation microarray analysis,21
could prove to be very valuable at least in a subgroup of patients
who may harbour X-chromosomal submicroscopic deletions.
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